China BioPharma Capital Invests in Quantapore, a Sequencing Device Maker

China BioPharma Capital led a Series C financing in Quantapore, a Bay Area sequencing device company. The financial details were not disclosed. China BioPharma Capital is a life science venture capital fund, based in Hong Kong, whose $50 million in initial capital came entirely from Chongqing Lummy Pharma. The fund is run by TVM Capital Life, a Munich-Montreal-Hong Kong investment firm, and plans to in-license China rights for drugs and devices from its portfolio companies. More details.... Stock Symbol: (SHZ: 300006) Share this with colleagues: // //